The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies – a European survey

Bone metastases in patients with solid tumours (ST) and bone lesions in patients with haematological malignancies (HM) are common. Associated skeletal‐related events (SREs) cause severe pain, reduced quality of life and place a burden on health care resources. Bone‐targeted agents can reduce the ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebret, T., Casas, A., Cavo, M., Woll, P.J., Deleplace, C., Kennedy, C., Schoen, P., Jackisch, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516244/
https://www.ncbi.nlm.nih.gov/pubmed/27072626
http://dx.doi.org/10.1111/ecc.12490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516244/
https://www.ncbi.nlm.nih.gov/pubmed/27072626
http://dx.doi.org/10.1111/ecc.12490

Ejemplares similares